Beam Enterprise Value Over E B I T D A from 2010 to 2024
| BEAM Stock | USD 25.70 0.23 0.89% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (11.74) | Current Value (12.33) | Quarterly Volatility 20.22800504 |
Check Beam TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beam main balance sheet or income statement drivers, such as Depreciation And Amortization of 21 M, Interest Expense of 49 M or Selling General Administrative of 122.7 M, as well as many exotic indicators such as Price To Sales Ratio of 5.28, Dividend Yield of 0.0106 or PTB Ratio of 2.25. Beam financial statements analysis is a perfect complement when working with Beam TherapeuticsInc Valuation or Volatility modules.
Beam | Enterprise Value Over E B I T D A |
Latest Beam TherapeuticsInc's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Beam TherapeuticsInc over the last few years. It is Beam TherapeuticsInc's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Beam TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Beam Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (22.86) | |
| Geometric Mean | 23.34 | |
| Coefficient Of Variation | (88.50) | |
| Mean Deviation | 15.20 | |
| Median | (32.70) | |
| Standard Deviation | 20.23 | |
| Sample Variance | 409.17 | |
| Range | 89.7901 | |
| R-Value | 0.41 | |
| Mean Square Error | 368.08 | |
| R-Squared | 0.16 | |
| Significance | 0.13 | |
| Slope | 1.84 | |
| Total Sum of Squares | 5,728 |
Beam Enterprise Value Over E B I T D A History
About Beam TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Beam TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Beam TherapeuticsInc investors use historical funamental indicators, such as Beam TherapeuticsInc's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Beam TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Beam TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Beam TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Beam TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Beam TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (11.74) | (12.33) |
Pair Trading with Beam TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Beam TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Beam Stock
| 0.74 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
Moving against Beam Stock
| 0.59 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |
| 0.44 | BIIB | Biogen Inc Financial Report 23rd of April 2024 | PairCorr |
| 0.42 | ABVC | ABVC Biopharma | PairCorr |
The ability to find closely correlated positions to Beam TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Beam TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Beam TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Beam TherapeuticsInc to buy it.
The correlation of Beam TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beam TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beam TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Beam TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Beam TherapeuticsInc Correlation against competitors. To learn how to invest in Beam Stock, please use our How to Invest in Beam TherapeuticsInc guide.Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Beam Stock analysis
When running Beam TherapeuticsInc's price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share 4.896 | Quarterly Revenue Growth 14.78 | Return On Assets (0.08) | Return On Equity (0.15) |
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.